Euler Biologics

Euler Biologics is a San Francisco-based biotech startup developing antibody-based therapies designed to preserve and enhance physical function for older adults. The company's mission is to help older adults stay stronger for longer, supporting healthy aging and maintaining functional independence. Euler Biologics focuses on the growing global challenge posed by aging populations and declining birthrates, believing novel biologic drugs can help societies avoid difficult tradeoffs between economic growth and elder care. The company is developing therapies targeting frailty and age-related functional decline. Euler Biologics is backed by Pillar VC and has participated in longevity-focused biotech communities including MBC BioLabs' Longevity Innovation Forum. The company was founded in 2024 and operates in the longevity and biologics therapeutic space.